|
ÈÞ¸¶½Ã½º |
2023 »ó¹Ý±â ÇÁ·Î±×·¥ °³¹ß ºÎ¹® °æ·Â(10~15³â) ä¿ë
°æ±â ±ºÆ÷½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
Àü»ê/Á¤º¸Åë½Å |
10³â¡è |
ä¿ë½Ã |
07.12 |
|
|
¹ÙÀÌ¿ÀÀÌÁî |
¹ÙÀÌ¿ÀÀÌÁî AptaSign ÀÓ»óÆÀ ¸ðÁý
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
10³â¡è |
ä¿ë½Ã |
05.11 |
|
|
(ÁÖ)´ëÇÑ´ºÆÊ |
´ëÇÑ´ºÆÊ ¸¶ÄÉÆÃÆÀ(ÁÖ»çÁ¦Ç° PM) °æ·Â»ç¿ø ¸ðÁý
°æ±â ¼º³²½Ã ¼öÁ¤±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
10³â¡è |
ä¿ë½Ã |
04.20 |
|
|
(ÁÖ)Çѱ¹ºñ¿£¾¾ |
CEÀÎÁõ/Çؿܵî·Ï/ÀÎÇã°¡(RA) °æ·ÂÀÚ Ã¤¿ë °ø°í
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
10³â¡è |
ä¿ë½Ã |
04.26 |
|
|
(ÁÖ)¹ÙÀÌ¿À´Ï¾Æ |
ÇÕ¼º»ý¹°ÇÐ ¿¬±¸ ÃÑ°ý ´ã´çÀÚ ¸ðÁý
´ëÀü ´ë´ö±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
10³â¡è |
ä¿ë½Ã |
11.23 |
|
|
(ÁÖ)¾Ë¹ÙÀÌ¿À |
¿¹¼ºÀÇ·áÀç´Ü ¾ç»êº£µ¥½º´Ù º´¿ø ±¸¸Å°ü¸® °æ·ÂÁ÷(ÆÀÀå) ä
°æ³² ¾ç»ê½Ã | ´ëÇÐ(2~3³â) Á¹¾÷ |
»ý»êÁö¿ø/¹°·ù/±¸¸Å |
10³â¡è |
ä¿ë½Ã |
02.20 |
|
|
ÄܹÙÅØÄÚ¸®¾Æ À¯ÇÑȸ»ç |
[¿Ü±¹°è ÀÇ·á±â±â] Sales supervisor - CCC
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
10³â¡è |
ä¿ë½Ã |
09.20 |
|
|
À̴ϽºÆ®¹ÙÀÌ¿ÀÁ¦¾à(ÁÖ) |
À̴ϽºÆ®¹ÙÀÌ¿ÀÁ¦¾à(ÁÖ) ÀλçºÎ¹® 10³âÀÌ»ó °æ·ÂÀÚ ¸ðÁý
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Àλç/ÀÎÀç°³¹ß/ä¿ë/±³À° |
10³â¡è |
ä¿ë½Ã |
11.30 |
|
|
Çʸ³½º ÄÚ¸®¾Æ |
Philips Korea-Consumer Marketing Manager-Male Grooming&B
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
10³â¡è |
ä¿ë½Ã |
10.18 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Field medical, Dupilumab (Medical manage
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
10³â¡è |
ä¿ë½Ã |
10.28 |
|
|
(ÁÖ)ÈÁø¸ÞµðÄ® |
ÈÁø¸ÞµðÄ® ȸ°è ¹× À繫 ÃÑ°ý °ü¸®ÀÚ ¸ðÁý
Ãæ³² õ¾È½Ã | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
10³â¡è |
ä¿ë½Ã |
02.19 |
|
|
(ÁÖ)¸¶ÀÌÅ©·Î¸Þµð |
¹ÙÀÌ¿À, ±â´É¼º¹ßÈ¿°Ç°½ÄÇ° ¿¬±¸¼ÒÀå/°øÀåÀå Ãʺù°ø°í
´ëÀü ´ë´ö±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
10³â¡è |
ä¿ë½Ã |
10.29 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
12.20 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
01.02 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Patient Advocacy Head
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
10³â¡è |
ä¿ë½Ã |
01.06 |
|